The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Ipsen
NAXIVA: A phase II neoadjuvant study of axitinib for reducing extent of venous tumor thrombus in clear cell renal cell cancer (RCC) with venous invasion.
 
Grant D. Stewart
Honoraria - EUSA Pharma; Merck; Pfizer
Consulting or Advisory Role - CMR Surgical
Research Funding - AstraZeneca; Pfizer
 
Sarah J. Welsh
No Relationships to Disclose
 
Stephan Ursprung
No Relationships to Disclose
 
Ferdia Gallagher
Honoraria - AstraZeneca (Inst); AstraZeneca (Inst)
Research Funding - GE Healthcare; GlaxoSmithKline; GlaxoSmithKline (I)
Travel, Accommodations, Expenses - CSL Behring (I)
 
Iosif Mendichovszky
No Relationships to Disclose
 
Antony Riddick
Consulting or Advisory Role - CMR Surgical
 
Tim Eisen
Employment - AstraZeneca; Roche
Leadership - AstraZeneca; Roche
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I)
Honoraria - Various
Consulting or Advisory Role - Various
Research Funding - AstraZeneca (Inst); Bayer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche
Other Relationship - Kidney Cancer UK; Macmillan Cancer Support
 
Steve Leung
No Relationships to Disclose
 
Alexander Laird
No Relationships to Disclose
 
Jahangeer Malik
No Relationships to Disclose
 
Grenville Oades
No Relationships to Disclose
 
Balaji Venugopal
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Pfizer
Consulting or Advisory Role - Ipsen; MSD Oncology; Pfizer/EMD Serono
Speakers' Bureau - MSD Oncology
Research Funding - Calithera Biosciences (Inst); MSD Oncology (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Ipsen
 
Faiz Mumtaz
No Relationships to Disclose
 
Axel Bex
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Pfizer (Inst)
 
Ekaterini Boleti
Speakers' Bureau - Merck
 
Abdel Hamid
No Relationships to Disclose
 
Kathleen Riddle
No Relationships to Disclose
 
Michelle Welsh
No Relationships to Disclose
 
Lisa Hopcroft
No Relationships to Disclose
 
Robert J. Jones
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EUSA Pharma; Ipsen; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Pharmacyclics; Roche/Genentech; Sanofi; Seagen
Consulting or Advisory Role - Clovis Oncology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; MSD